Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.83B |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.52B |
| 3 |
UBS Group
UBS
|
+$1.11B |
| 4 |
Johnson & Johnson
JNJ
|
+$920M |
| 5 |
Bank of America
BAC
|
+$919M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.98B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.37B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$931M |
| 5 |
Coca-Cola
KO
|
+$880M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.24% |
| 2 | Financials | 15.7% |
| 3 | Technology | 13.61% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Ulta Beauty
ULTA
$23.1B
| $252M | 0.03% |
1,971,385
-193,059
| -9% | -$23.7M |
|
577
Acadia Realty Trust
AKR
$2.85B
| $252M | 0.03% |
7,865,466
+338,400
| +4% | +$10.5M |
|
|
ACOR
578
DELISTED
Acorda Therapeutics
ACOR
| $252M | 0.03% |
51,303
+607
| +1% | +$2.6M |
|
579
Allstate
ALL
$65.2B
| $251M | 0.03% |
3,573,955
+144,058
| +4% | +$9.48M |
|
580
Tapestry
TPR
$31B
| $251M | 0.03% |
6,679,728
+1,590,172
| +31% | +$56.1M |
|
|
SEE
581
DELISTED
Sealed Air
SEE
| $250M | 0.03% |
5,889,405
+3,377,362
| +134% | +$127M |
|
582
Novartis
NVS
$290B
| $249M | 0.03% |
3,003,916
+184,940
| +7% | +$15.3M |
|
583
Cousins Properties
CUZ
$4.86B
| $249M | 0.03% |
7,736,181
+3,797,076
| +96% | +$130M |
|
|
MFA
584
MFA Financial
MFA
$928M
| $249M | 0.03% |
7,775,414
+172,363
| +2% | +$5.68M |
|
|
ESND
585
DELISTED
Essendant Inc.
ESND
| $248M | 0.03% |
5,879,542
| – | – |
|
|
CPN
586
DELISTED
Calpine Corporation
CPN
| $248M | 0.03% |
11,197,036
+3,349,227
| +43% | +$74.3M |
|
587
Sally Beauty Holdings
SBH
$1.52B
| $247M | 0.03% |
8,034,515
+313,001
| +4% | +$9.3M |
|
588
Signet Jewelers
SIG
$3.6B
| $246M | 0.03% |
1,868,785
+1,154,972
| +162% | +$140M |
|
589
Celldex Therapeutics
CLDX
$3.5B
| $245M | 0.03% |
895,891
+91,853
| +11% | +$22.8M |
|
590
Synopsys
SNPS
$79.3B
| $245M | 0.03% |
5,633,887
-65,886
| -1% | -$2.74M |
|
591
AGNC Investment
AGNC
$13B
| $245M | 0.03% |
11,202,172
+86,589
| +0.8% | +$1.95M |
|
|
PCYC
592
DELISTED
PHARMACYCLICS INC
PCYC
| $244M | 0.03% |
1,999,286
-5,306
| -0.3% | -$678K |
|
593
Cimpress
CMPR
$2.33B
| $244M | 0.03% |
3,259,764
+2,366,848
| +265% | +$154M |
|
594
Emerson Electric
EMR
$91.6B
| $244M | 0.03% |
3,945,539
-1,070,512
| -21% | -$67.1M |
|
|
CMRX
595
DELISTED
Chimerix, Inc.
CMRX
| $242M | 0.03% |
6,017,763
+667,346
| +12% | +$22.6M |
|
596
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $242M | 0.03% |
4,598,708
+793,350
| +21% | +$41.8M |
|
597
Innoviva
INVA
$1.52B
| $242M | 0.03% |
17,087,423
+2,103,759
| +14% | +$31.6M |
|
598
Generac Holdings
GNRC
$13B
| $241M | 0.03% |
5,151,795
+1,273,785
| +33% | +$55.7M |
|
|
HME
599
DELISTED
HOME PROPERTIES, INC
HME
| $241M | 0.03% |
3,667,564
-306,974
| -8% | -$19.6M |
|
600
Nasdaq
NDAQ
$53.2B
| $240M | 0.03% |
15,013,320
-144,336
| -1% | -$2.12M |
|
Similar funds
Fidelity Investments's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity Investments held 2,940 positions worth $769B, up 4.1% from $738B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Fidelity Investments's Q4 2014 filing shows 176 new, 1,100 increased, 1,140 reduced and 160 closed positions. Its largest new stake was UBS Group: 64,914,641 shares worth $1.11B. The largest sale was AbbVie, an estimated $2.98B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
- Fidelity Investments's largest Q4 2014 buy was UBS Group: 64,914,641 shares worth $1.11B.
- Fidelity Investments added most to Medtronic in Q4 2014, an estimated $1.83B increase.
- Fidelity Investments's biggest Q4 2014 reduction was AbbVie, cutting an estimated $2.98B.
- Fidelity Investments fully exited TIM HORTONS INC COM, CANADA in Q4 2014, selling an estimated $693M.
- Fidelity Investments's ten largest holdings make up 14% of its $769B portfolio in Q4 2014.
- Fidelity Investments opened 176 new positions and closed 160 in Q4 2014.
- Fidelity Investments's portfolio value rose 4.1% quarter-over-quarter to $769B.
Based on Fidelity Investments's 13F filing for Q4 2014, filed 17 Feb 2015.